Within this context, Enhancer of Zeste Homolog 2 (EZH2) mRNA emerges as a histone methyltransferase gene responsible for adding methyl groups to histone proteins and raised in cervical cancer [127]. This evidence concerns the gene PRDM9 and cervical cancer.